EDEN PRAIRIE, Minn., Aug. 25, 2022 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to ...
First commercially available cell culture solution for HEK293 cells and perfusion -– optimized for high cell density (HCD), intensified processes and perfusion cultures Additional capabilities for ...
Aidoc, the leading clinical AI platform, today announced strategic partnerships with Cercare Medical and Circle CVI to expand ...
New Modes Are Beginning to Gain Ground on Fed-batch Strategy The therapeutic success of highly efficacious complex biologicals that are almost exclusively produced in cell culture such as antibodies ...
WALTHAM, Mass.--(BUSINESS WIRE)--Paragonix Technologies, a pioneer in organ transplant technologies and organ procurement services, announced today the completion of the world’s first donor kidney ...
ANDOVER, Mass., Aug. 2, 2023 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with ...
CHICAGO, IL / ACCESS Newswire / November 28, 2025 / Cercare Medical will unveil its latest innovation-CBCT Perfusion-at RSNA 2025, held November 30 to December 4 at McCormick Place in Chicago.
The perfusion of a burn injury can now rapidly be determined by using a new technique. Using the perfusion image made by a laser and an ultra fast camera, doctors will be able to determine whether a ...
FUJIFILM Biosciences, a global leader in the innovation and manufacture of cell culture solutions for the Life Science market, today announced the commercial launch of BalanCD HEK293 Perfusion A.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results